Home / Netherlands / Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
689 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
July 31, 2015 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Lakefront Biotherapeutics NV by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 24, 2020 | Citadel Advisors LLC | 0.96% | |
| February 19, 2020 | Marshall Wace LLP | 1.20% | |
| February 17, 2020 | D. E. Shaw & Co., L.P. | 1.00% | |
| February 6, 2020 | Citadel Advisors LLC | 0.80% | |
| February 5, 2020 | Marshall Wace LLP | 1.11% | |
| February 5, 2020 | Numeric Investors LLC | 0.58% | |
| February 5, 2020 | Millennium International Management LP | 0.49% | |
| February 4, 2020 | D. E. Shaw & Co., L.P. | 0.93% | |
| February 4, 2020 | Citadel Advisors LLC | 0.77% | |
| February 3, 2020 | Citadel Advisors LLC | 0.80% | |
| January 31, 2020 | Marshall Wace LLP | 1.01% | |
| January 27, 2020 | Marshall Wace LLP | 0.90% | |
| January 24, 2020 | Citadel Advisors LLC | 0.70% | |
| January 22, 2020 | Marshall Wace LLP | 0.80% | |
| January 20, 2020 | Marshall Wace LLP | 0.70% | |
| January 15, 2020 | D. E. Shaw & Co., L.P. | 1.08% | |
| January 15, 2020 | Marshall Wace LLP | 0.62% | |
| January 13, 2020 | Numeric Investors LLC | 0.61% | |
| January 13, 2020 | Marshall Wace LLP | 0.59% | |
| January 10, 2020 | Marshall Wace LLP | 0.60% | |
| January 9, 2020 | Numeric Investors LLC | 0.59% | |
| January 6, 2020 | Marshall Wace LLP | 0.58% | |
| January 3, 2020 | D. E. Shaw & Co., L.P. | 1.10% | |
| January 2, 2020 | Marshall Wace LLP | 0.60% | |
| December 31, 2019 | Marshall Wace LLP | 0.59% | |
| December 30, 2019 | Millennium International Management LP | 0.53% | |
| December 27, 2019 | AQR Capital Management, LLC | 0.47% | |
| December 18, 2019 | AQR Capital Management, LLC | 0.59% | |
| December 17, 2019 | AQR Capital Management, LLC | 0.66% | |
| December 17, 2019 | Marshall Wace LLP | 0.61% | |
| December 16, 2019 | AQR Capital Management, LLC | 0.77% | |
| December 16, 2019 | Numeric Investors LLC | 0.61% | |
| December 13, 2019 | AQR Capital Management, LLC | 0.80% | |
| December 11, 2019 | Marshall Wace LLP | 0.58% | |
| December 10, 2019 | Numeric Investors LLC | 0.51% | |
| December 9, 2019 | AQR Capital Management, LLC | 0.79% | |
| December 5, 2019 | AQR Capital Management, LLC | 0.87% | |
| December 5, 2019 | Millennium International Management LP | 0.49% | |
| December 2, 2019 | AQR Capital Management, LLC | 0.98% | |
| November 26, 2019 | D. E. Shaw & Co., L.P. | 1.09% | |
| November 26, 2019 | AQR Capital Management, LLC | 1.03% | |
| November 26, 2019 | Marshall Wace LLP | 0.64% | |
| November 26, 2019 | Citadel Advisors LLC | 0.60% | |
| November 26, 2019 | Millennium International Management LP | 0.56% | |
| November 25, 2019 | D. E. Shaw & Co., L.P. | 0.98% | |
| November 22, 2019 | AQR Capital Management, LLC | 1.14% | |
| November 21, 2019 | AQR Capital Management, LLC | 1.21% | |
| November 19, 2019 | Marshall Wace LLP | 0.77% | |
| November 18, 2019 | AQR Capital Management, LLC | 1.37% | |
| November 15, 2019 | AQR Capital Management, LLC | 1.45% |
Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.86% of the capital sold short
- Pharming Group N.V. 7.95% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.65% of the capital sold short
- Fugro N.V. 4.20% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- NSI N.V. 2.01% of the capital sold short
- Alfen N.V. 1.85% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=7